These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21168488)

  • 1. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
    Taghdisi SM; Lavaee P; Ramezani M; Abnous K
    Eur J Pharm Biopharm; 2011 Feb; 77(2):200-6. PubMed ID: 21168488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
    Danesh NM; Lavaee P; Ramezani M; Abnous K; Taghdisi SM
    Int J Pharm; 2015 Jul; 489(1-2):311-7. PubMed ID: 25936625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM; Abnous K; Mosaffa F; Behravan J
    J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles.
    Taghdisi SM; Danesh NM; Lavaee P; Emrani AS; Hassanabad KY; Ramezani M; Abnous K
    Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():753-61. PubMed ID: 26838906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
    Luo YL; Shiao YS; Huang YF
    ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of structural modifications of daunorubicin on in vitro antileukemic activity.
    Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
    Anticancer Res; 2012 Dec; 32(12):5271-7. PubMed ID: 23225426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polyvalent aptamer system for targeted drug delivery.
    Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
    Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells.
    Gu YJ; Cheng J; Jin J; Cheng SH; Wong WT
    Int J Nanomedicine; 2011; 6():2889-98. PubMed ID: 22131835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional single-walled carbon nanotubes based on an integrin alpha v beta 3 monoclonal antibody for highly efficient cancer cell targeting.
    Ou Z; Wu B; Xing D; Zhou F; Wang H; Tang Y
    Nanotechnology; 2009 Mar; 20(10):105102. PubMed ID: 19417509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High-density lipoproteins as a form of daunorubicin transport in hepatoma cells of mice].
    Sumenkova DV; Poliakov LM; Panin LE
    Eksp Klin Farmakol; 2012; 75(5):32-4. PubMed ID: 22834127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new daunomycin-peptide conjugate: synthesis, characterization and the effect on the protein expression profile of HL-60 cells in vitro.
    Orbán E; Manea M; Marquadt A; Bánóczi Z; Csík G; Fellinger E; Bosze S; Hudecz F
    Bioconjug Chem; 2011 Oct; 22(10):2154-65. PubMed ID: 21950465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic nanotubes for drug loading and cellular delivery.
    Wakasugi A; Asakawa M; Kogiso M; Shimizu T; Sato M; Maitani Y
    Int J Pharm; 2011 Jul; 413(1-2):271-8. PubMed ID: 21540092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel near-infrared protein assay based on the dissolution and aggregation of aptamer-wrapped single-walled carbon nanotubes.
    Chen H; Yu C; Jiang C; Zhang S; Liu B; Kong J
    Chem Commun (Camb); 2009 Sep; (33):5006-8. PubMed ID: 19668831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategy for label-free and time-resolved luminescent assay of protein: conjugate Eu3+ complex and aptamer-wrapped carbon nanotubes.
    Ouyang X; Yu R; Jin J; Li J; Yang R; Tan W; Yuan J
    Anal Chem; 2011 Feb; 83(3):782-9. PubMed ID: 21207953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactic acid) (PLA) based nanocomposites--a novel way of drug-releasing.
    Chen C; Lv G; Pan C; Song M; Wu C; Guo D; Wang X; Chen B; Gu Z
    Biomed Mater; 2007 Dec; 2(4):L1-4. PubMed ID: 18458473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid biohybrid nanocarriers with high-therapeutic payload and controllable extended release of daunomycin for cancer therapy.
    Whitener R; Mosley RJ; Wower J; Byrne ME
    J Biomed Mater Res A; 2021 Jul; 109(7):1256-1265. PubMed ID: 33047466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
    Russo D; Piccaluga PP; Michieli M; Michelutti T; Visani G; Gugliotta L; Bonini A; Pierri I; Gobbi M; Tiribelli M; Fanin R; Piccolrovazzi S; Baccarani M
    Ann Hematol; 2002 Aug; 81(8):462-6. PubMed ID: 12224004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia.
    Bellott R; Auvrignon A; Leblanc T; Pérel Y; Gandemer V; Bertrand Y; Méchinaud F; Bellenger P; Vernois J; Leverger G; Baruchel A; Robert J
    Cancer Chemother Pharmacol; 2001; 47(1):15-21. PubMed ID: 11221955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
    Li R; Wu R; Zhao L; Wu M; Yang L; Zou H
    ACS Nano; 2010 Mar; 4(3):1399-408. PubMed ID: 20148593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
    Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
    Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.